Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy: A Randomized, Multicenter, Multinational Study

NCT01291641 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01291641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01291641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy: A Randomized, Multicenter, Multinational Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2011
Completion date
March 31, 2017
Enrollment
342 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemias